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Abstract
Background Healthy lifestyle might improve outcome
among colorectal cancer (CRC) survivors. In this study we
investigated the proportion of survivors who meet recom-
mended lifestyle and weight guidelines and compared this
to the general population. Factors that predict current
behaviour were also assessed.
Method A random sample of CRC survivors diagnosed
between 1998 and 2007 were surveyed. Percentages of
current smokers, alcohol consumers, excess weight and
clustering of these variables were calculated. Using logistic
regression we assessed demographical and clinical factors
that predict current lifestyle and excess weight.
Results We included 1349 (74% response rate) survivors
in this study of whom only 8 and 16% of male and female
survivors met the recommended lifestyle and body weight.
Among male survivors up to 10% had at least two unhealthy
lifestyle factors and among women, up to 19%. The pro-
portion of smokers and those who had ever consumed
alcohol was lower compared to the general population (13
vs. 31%, 82 vs. 86% respectively), but excess weight (BMI
at least 25 kg/m2) was more prevalent among survivors
(69 vs. 53% respectively). Having received chemotherapy
was significantly associated with being overweight (adjusted
odd ratio 1.5, 95% confidence interval 1.05–2.3). Younger
patients, male gender and survivors of lower socioeconomic
status were more likely to show non-compliance to healthy
lifestyle recommendations.
Conclusion The observed clustering of unhealthy life-
style warrants interventions targeting multiple behaviours
simultaneously. Reducing excess weight should be one of
the most important targets of interventions, particularly for
males, those who had chemotherapy and survivors of lower
socioeconomic status.
Keywords Alcohol  Colorectal cancer  Body mass
index  Smoking  Survivors
Introduction
Colorectal cancer (CRC) is one of the most common can-
cers in developed countries, and its incidence continues to
rise. In 2008, 12000 new patients were diagnosed with
CRC in the Netherlands as compared to 7000 cases in 1998
[1]. On the other hand, mortality has decreased and sur-
vivorship has improved, leading to an increase in the
prevalence of CRC survivors. The number of CRC survi-
vors is predicted to be 67000 by 2015, almost double the
observed number for the year 2000 (34000 survivors) [2].
Lifestyle is an important factor that modifies outcomes
including survival and quality of life among CRC survivors
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[3–6]. However, in terms of the lifestyle behaviour clusters
(physical activity, fruit and vegetable consumption, and
smoking), only 5% of cancer survivors meet all healthy
living recommendations [7].
In this study we aimed to describe the prevalence of
healthy behaviours on the basis of a population-based
sample of CRC survivors. At the same time we also
assessed demographical and clinical factors that were
related to the current opted lifestyle among survivors.
Method
In 2009 postal questionnaires were sent to assess health
status among a random sample of 1682 CRC survivors
within a population-based cancer registry in the south of
the Netherlands. This registry (Eindhoven Cancer Registry,
ECR) records data of all newly diagnosed cancer cases
within an area of 2.4 million inhabitants. For this study, all
CRC patients recorded in the ECR database who were
diagnosed with the cancer between 1998 and 2007 were
eligible for participation. We randomly selected survivors
using weights based on cancer site, sex and year of diag-
nosis. The weights were derived from the total distribution
of CRC survivors in the ECR region. Survivors with
shorter years of follow-up since diagnosis were oversam-
pled for inclusion in future follow-up assessments. Medical
specialists sent their (former) patients a letter to inform
them about the study, with the questionnaire attached to it.
If the questionnaire was not returned within 2 months, a
reminder-letter with an additional copy of the questionnaire
was sent. A more detailed explanation on the procedure of
the data collection has been described elsewhere [8, 9].
Approval for this study was obtained from a local certified
medical ethics committee.
Data on clinical characteristics (tumour stage at diag-
nosis [10], type of primary treatment (surgery, chemother-
apy and radiotherapy) and comorbidity [11]) were obtained
from the registry as well as data on age, sex and socio-
economic class (based on zip codes [12]). Major lifestyle
behaviours were assessed using standardized questionnaires
on smoking (non-smokers, ex-smokers and smokers) and
alcohol consumption (non-drinkers, ex-drinkers and drink-
ers). In addition we also described body mass index (BMI)
based on self-reported body height and weight. Normal
weight was defined as BMI less than 25 kg/m2, overweight
as BMI 25–29.9 kg/m2 and obesity as BMI at least
30 kg/m2. Reported lifestyle factors by age groups were
retrieved from the national household survey of the Netherlands
Statistics Office to serve as a reference for the general Dutch
population [13] and to enable comparison with our cohort.
This survey is performed annually on about 10000 persons
using computer-assisted personal interviewing.
Analysis
Analyses were based on 1349 survivors who responded
(74% response rate) to the questionnaire and to one or more
questions on lifestyle factors that we examined. We
determined proportions of smoking and alcohol intake
history, excess weight and clustering of one or more
unhealthy behaviours or excess weight among the survi-
vors. Statistical difference between the groups among the
survivors was tested using Fisher’s exact test and we
considered the difference to the null hypothesis to be sig-
nificant if the p value was lower than 0.05. Finally, we
performed a logistic regression analysis to estimate the
relation between patients’ or clinical factors with current
unhealthy behaviour or weight. Dependent factors (life-
styles and BMI) were each grouped into two categories
(current smoking: yes or no; alcohol consumption: current
consumption or not; excess weight (BMI at least 25 kg/m2):
yes or no). In the analysis we included gender, age at diag-
nosis, socioeconomic factors, cancer stage, comorbidity
at diagnosis and time since diagnosis. All statistical analyses
were performed using Stata (version 11 for Windows,
StataCorp, TX, USA).
Results
Table 1 summarizes the characteristics of the CRC survi-
vors included in this study as well as of those who did not
respond to the questionnaire or had missing values for
behaviour- or BMI-related questions. Non-responders were
more likely to be older than 65 years, had cancer of the
colon and had one or more comorbidity at time of diag-
nosis. The elderly was the largest group in our study,
comprising 57% of the survivors included, who responded
to the questionnaire and therefore generally they had other
coexisting illness at the time of diagnosis (52%). More than
half of the responders (58%) were diagnosed with CRC
2–5 years before the survey took place and were diagnosed
with stage I or II CRC (28 and 38%, respectively).
Table 2 presents the distribution of lifestyle factors
among the CRC survivors. In this table we included the
same results as reported from the national household sur-
vey. Participants in these surveys are selected on the basis
of a random sample of the population registered in the
cancer registry (for the survivors) or the municipality (for
the general population). Because of the difference in age
pattern in the two background populations, i.e. older people
among the survivors, comparison in Table 2 should be
done with caution. Comparisons are presented by age
groups to circumvent the bias that might be introduced
because of the difference in the age distribution of the two
populations. Compared to the general population, CRC
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survivors were less likely to be a current smoker or to ever
have consumed alcohol. Thirteen per cent of male survi-
vors currently smoke cigarettes as compared to 31% among
the general population, whereas 8 and 23% females
smoked among the survivors and the general population
respectively. Similar observations were found by age
groups. A significant higher proportion of smokers was
observed for male and younger survivors. Excess weight
was more common among CRC survivors than in the
general Dutch population [64% (48% with BMI
25–29.9 kg/m2 and 16% with BMI at least 30 kg/m2) vs.
47% (35% with BMI 25–29.9 kg/m2 and 12% BMI at least
30 kg/m2) respectively]. Among the survivors, males had
significantly higher BMI than females. However, unlike
smoking and alcohol consumption, BMI did not signifi-
cantly vary by age groups.
Table 3 shows the clustering between lifestyle factors
and excess weight among the CRC survivors in our study.
Among male and female survivors, only 8 and 18%
respectively were non-smokers, alcohol abstainers and of
normal weight. Male survivors had a stronger clustering of
risk factors that include smoking compared to females
(smoker and alcohol consumer 10 versus 4% or smoker and
excess weight 8 versus 4% for male and female, respec-
tively). On the other hand, more female survivors were, at
the same time, overweight and alcohol consumers as
compared to males (19 vs. 9% respectively).
Table 1 Characteristics of CRC survivors according to response
Respondersa
(number, %)
Non-responders
(number, %)
p value
Age at diagnosis (years) \0.001
25–44 38 (3) 12 (4)
45–64 548 (41) 97 (29)
C65 763 (57) 225 (67)
Site 0.021
Colon 892 (66) 243 (73)
Rectum 457 (34) 91 (27)
Stage 0.168
I 381 (28) 89 (27)
II 517 (38) 146 (44)
III 382 (28) 89 (27)
IV 69 (5) 10 (3)
Years since diagnosis 0.460
\2 163 (12) 40 (12)
2–4.9 784 (58) 183 (55)
C5 402 (30) 111 (33)
Socioeconomic status 0.508
I (lowest) 289 (21) 78 (23)
II 522 (39) 138 (41)
III (highest) 469 (35) 100 (30)
Institutionalized 32 (2) 10 (3)
Unknown 37 (3) 8 (2)
Comorbidity at diagnosis 0.005
No 538 (40) 101 (30)
Yes/at least one
condition
705 (52) 204 (61)
Unknown 106 (8) 29 (9)
Total 1349 334
a Responded to question on smoking status, alcohol consumption or
body weight and height
Table 2 Lifestyle factor prevalence among CRC survivors as com-
pared to general population of the Netherlands in 2009
Lifestyles/characteristics Survivors (%) Population (%)
Current smokersa by sexb
Male 13 31
Female 8 23
Current smokersa per age group (age at survey, years)b
25–44 22 33
45–64 17 29
C65 8 15
BMIa (kg/m2) by sexb
Male 25–29: 54 25–29: 41
C30: 14 C30: 11
Female 25–29: 40 25–29: 30
C30: 18 C30: 12
BMIa (kg/m2) by age group (age at survey, years)
25–44 25–29: 42 25–29: 31
C30: 11 C30: 10
45–64 25–29: 43 25–29: 41
C30: 17 C30: 14
C65 25–29: 50 25–29: 42
C30: 15 C30: 15
Abstainer (alcohol)a by genderb
Male 18 14
Female 50 26
Abstainera by age group (age at survey, year)b
25–44 38 14
45–64 23 15
C65 38 28
Out of 1349 responders, 1296 reported their weight and height
(missing: 4%), 1294 reported their smoking status (missing: 4%) and
949 reported their alcohol intake (missing: 29%)
a Lifestyle factors including smoking status, alcohol consumption
and BMI were categorised as follows: (1) current smoking: yes or no
(includes lifelong non-smokers and ex-smokers), (2) alcohol consump-
tion: abstainer and not (includes ex-consumer and current consumer)
and (3) BMI 25–29.9 kg/m2 for overweight and BMI C 30 kg/m2 for
obese
b Exact Fisher test for comparison of proportions between subgroups
among CRC survivors were significant with a p value less than 0.05
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Table 4 describes the relation between patient charac-
teristics (at the time of diagnosis) and current behaviour or
BMI. Female CRC patients were less likely than males to
currently smoke [odds ratio (OR) 0.5, 95% confidence
interval (95CI) 0.4–0.8], consume alcohol (OR 0.3, 95CI
0.2–0.4) or be overweight (OR 0.6, 95CI 0.5–0.8). Survi-
vors from the lowest socioeconomic group were more
likely to be current smokers (OR 1.8, 95CI 1.1–3.0) and
overweight (OR 1.5, 95CI 1.1–2.1) than those from the
highest socioeconomic groups. Additionally, we analysed
the impact of chemotherapy on current BMI and found that
chemotherapy significantly increased the odds of excess
weight by 50% (OR 1.5, 95CI 1.05–2.3, adjusted for the
all covariates). Alcohol consumption at the time of the
study was also more likely among those who received
chemotherapy.
Table 3 Clustering of lifestyle factors and excess weight among CRC survivors according to gender
Male (%) Female (%) p valuea
Currently smoke, consume alcohol and excess weight 5.9 1.9 0.000
Currently smoke and consume alcohol 9.8 3.6 0.000
Currently smoke and excess weight 7.8 4.3 0.037
Currently consume alcohol and excess weight 9.0 19.4 0.002
Non-smokers, alcohol abstainers and normal weight 7.8 17.5 0.000
Lifestyle factors including smoking status, alcohol consumption and BMI were categorised as follows: (1) current smoking: yes or no (includes
lifelong non-smokers and ex-smokers), (2) alcohol consumption: yes and no (includes ex-consumer or never consumed alcohol) and (3) BMI
25–29.9 kg/m2 for overweight and BMI C 30 kg/m2 for obese. Out of 1349 survivors included in the study 907 (67%) responded to all three
questions (smoking, alcohol consumption and weight and height)
a Exact Fisher test on proportional difference between male and female survivors
Table 4 Demographic and clinical factors that predict current smoking, alcohol consumption and excess weight: multivariate analysis
Smokinga
[OR (95CI)]b
Alcohola
[OR (95CI)]b
Excess weighta
[OR (95CI)]b
Gender (ref: male)
Female 0.5 (0.4–0.8) 0.3 (0.2–0.4) 0.6 (0.5–0.8)
Age (years) at diagnosis (ref: C65)
25–44 3.4 (1.3–9.0) 2.4 (0.9–6.6) 1.2 (0.5–2.6)
45–64 2.5 (1.7–3.8) 1.9 (1.4–2.6) 1.0 (0.7–1.3)
Site (ref: colon)
Rectum 1.2 (0.8–1.8) 0.7 (0.5–1.0) 0.8 (0.6–1.1)
Stage (ref: stage I)
II 2.1 (1.3–3.5) 1.0 (0.7–1.4) 1.2 (0.8–1.6)
III 1.3 (0.8–2.3) 0.9 (0.6–1.4) 1.2 (0.8–1.6)
IV 2.3 (1.0–5.2) 0.5 (0.3–1.0) 1.0 (0.6–1.9)
Time (years) since diagnosis (ref: \2 years)
2–4.9 0.9 (0.5–1.8) 1.0 (0.7–1.6) 1.1 (0.7–1.6)
C5 0.6 (0.3–1.1) 0.8 (0.5–1.4) 0.9 (0.6–1.4)
SES (ref: III: highest SES)
I (lowest) 1.8 (1.1–3.0) 0.4 (0.2–0.5) 1.5 (1.1–2.1)
II (middle) 1.5 (1.0–2.3) 0.9 (0.6–1.3) 1.3 (1.0–1.7)
Comorbidity at diagnosis (ref: none)
Yes 1.1 (0.7–1.6) 0.6 (0.4–0.8) 1.78 (1.4–2.3)
Chemotherapy
Yes 0.9 (0.5–1.6) 1.7 (1.1–2.7) 1.5 (1.1–2.3)
a Lifestyle factors including smoking status, alcohol consumption and BMI were categorised as follows: (1) current smoking: yes or no (includes
lifelong non-smokers and ex-smokers), alcohol consumption: yes and no (includes ex-consumer or never consumed alcohol) and (3) excess
weight: overweight (BMI 25–29.9 kg/m2) and obese (BMI C 30 kg/m2)
b OR (95CI) odds ratio (95% confidence interval) adjusted for age at diagnosis, gender, site, stage, time since diagnosis, socioeconomic status
and comorbidity at diagnosis
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Discussion
In our population-based study, only 8 and 18% of male and
female CRC survivors met the advised healthy lifestyle of
not smoking, not drinking alcohol and having a normal
body weight. Although the prevalence of current smokers
and alcohol consumption among survivors was lower as
compared to the general Dutch population, more than 28%
of the survivors had two or more unhealthy lifestyle fac-
tors. Survivors also showed a larger proportion of excess
weight as compared to the general population. We found
that gender, socioeconomic status and chemotherapy were
significantly associated with current opted unhealthy life-
style or weight in our study.
Similar to our findings, previous studies reported lower
prevalence of unhealthy lifestyle factors, namely smoking,
among survivors compared to the general population
(Table 5) [1, 5, 14, 15]. As compared to the proportion of
smokers reported among CRC survivors in most studies in
the USA, smoking was less prevalent among US survivors
than among Dutch survivors [7]. Prevalence of smoking
among the general population is also lower in the USA
(21% [16]) than in the Netherlands (27% [13]), suggesting
that population-level tobacco policy also influences
behaviour of certain group such as cancer survivors. The
low prevalence of smoking and alcohol consumption
among survivors in our study, even though these lifestyles
are accomplished risk factors for CRC [17], might be
explained by two causes: firstly unhealthy lifestyles
increase mortality either due to CRC or other causes. Thus
current survivors may smoke or drink less because some of
the smokers or drinkers have died earlier after CRC diag-
nosis. Secondly, survivors are a group more motivated to
change their lifestyle [18], thus the lower prevalence of
smoking and alcohol drinking.
Excess weight seems to be a prominent issue among the
survivors. It remained a long-term problem among survi-
vors; in our study BMI did not differ between those diag-
nosed 6–24 months ago with those diagnosed 24–49 or
longer than 50 months before the questionnaire was com-
pleted (results not shown). This was observed despite the
fact that some cancer survivors can be malnourished and
underweight at diagnosis due to advanced disease or as a
result of aggressive treatment. Some of these underweight
patients might have died early after diagnosis, resulting in
an over-representation of longer-term survivors with excess
weight [4]. On the other hand, excess weight is a known
risk factor for CRC [19]. This might be the reason for the
large prevalence of survivors with excess weight in addi-
tion to the previously mentioned fact (possible over-rep-
resentation of survivors with excess weight). This is further
compounded by the fact that chemotherapy has been rela-
ted to weight gain [6]. Current alcohol intake was also T
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associated with a history of chemotherapy. Yet other
studies have never reported this and there is not yet any
plausible biological explanation behind this finding, so
there is currently no reason to think that this result has
meaningful impact. On the other hand, we found a 50%
higher odds of being overweight even after correcting for
age, sex, follow-up time and other possible confounders. A
few clinical trials on the use of various chemotherapies,
mainly comparing oxalipatin, 5-fluorouracil and folinic
acid (FOLFOX), reported that 8–40% of the patients on the
therapy gained significant weight [20–22]. Research on the
relation between chemotherapy and weight gain among
CRC patients was scarce or almost non-existent. For breast
cancer, chemotherapy has been related to factors such as
(a) changes in resting metabolic rate, (b) thermogenesis,
(c) reduced physical activity, and (d) change in dietary
habit (more snacking due to nausea related to chemother-
apy). One or more of these mechanisms may also play a
role in weight gain among CRC patients who received
chemotherapy, though research specifically for CRC
patients is needed.
Our study showed that among CRC survivors, those who
are male and/or belonging to the lowest socioeconomic
groups were more likely to have an unhealthy lifestyle.
Survivors who had chemotherapy or other illness at diag-
nosis were also more often overweight. These groups seem
to be a good target for intervention programs aimed at
improving lifestyle or body weight. The low level of
reported physical activity among survivors, also at
12 months since diagnosis [14], suggests a window of
opportunity to gain healthy weight through increased
physical activity. Furthermore, unhealthy BMI may
increase occurrence of comorbid cardiovascular diseases
among CRC survivors, thus impairing prognosis [14]. So
overall, obtaining a healthy weight through diet and
physical activity should be one of the main health messages
to be promoted among the survivors.
Our results also showed that 28–33% of the survivors
had two or more unhealthy lifestyle factors combined with
excess weight. This clustering suggests that a lifestyle
intervention targeting multiple behaviours at the same time
rather than single behavioural intervention program should
be developed for these survivors.
Strengths and limitations of the study
Our data is based on a large population-based database
from a random sample of the survivors with differing years
of follow-up, thus ensuring its representativeness of CRC
survivors in general in the Netherlands. We did not collect
historical (behavioural) data because this might be subject
to reporting bias. Currently, a follow-up study is being
carried out allowing assessment in lifestyle change and its
impact on outcome [23]. As a result of the lack of com-
parison to cancer patients who did not survive CRC, this
study is therefore not meant to identify causal link between
lifestyle and survivorship. The findings in this study are
based on a cross-sectional survey and should be interpreted
with caution. There is likely a survival bias in our sample:
those who adopted unhealthy lifestyle were more likely to
have died before our study as compared to those who have
a healthy lifestyle. Moreover, the elderly and those with
comorbidity responded less often to our questionnaire on
lifestyle or body weight and height. This may lead to an
underestimation of the need for promotion of healthier
lifestyle among the CRC survivors in these groups. Finally
we took aggregated results of lifestyle and BMI data
reported from national survey and used it for comparison to
our results. The average age of a sample of CRC survivors
from the population is probably higher than a random
sample of the general population. Lifestyle is known to
differ by age groups, and this may modify comparison
between the two groups. Therefore, to overcome this
problem, age group comparison was presented in our
results.
Conclusion
Only 8–16% of CRC survivors met all three recommended
guidelines of not smoking, not drinking alcohol and having
a normal body weight. One of the main health promotion
packages for these survivors should include strategies for
(re-)gaining healthy weight. Our study calls for multiple
behavioural intervention strategies at patient and commu-
nity level.
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